Synthesis of 2-,4,-6-, and/or 7-substituted quinoline derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors and anticancer agents: 3D QSAR-assisted design
作者:Vivek K. Vyas、Gulamnizami Qureshi、Drashti Oza、Hardik Patel、Krupali Parmar、Palak Patel、Manjunath D. Ghate
DOI:10.1016/j.bmcl.2019.01.038
日期:2019.4
(hDHODH) inhibitors as anticancer agents, herein we describe 3D QSAR-based design, synthesis and in vitro screening of 2-,4,-6-, and/or 7-substituted quinoline derivatives as hDHODH inhibitors and anticancer agents. We have designed 2-,4,-6-, and/or 7-substituted quinoline derivatives and predicted their hDHODH inhibitory activity based on 3D QSAR study on 45 substituted quinoline derivatives as hDHODH
在我们研究人类二氢乳清酸脱氢酶(hDHODH)抑制剂作为抗癌剂之后,在此我们描述了基于3D QSAR的2、4、6,和/或7-取代的喹啉衍生物作为hDHODH抑制剂的设计,合成和体外筛选。和抗癌药。我们设计了2-,4,-6和/或7-取代的喹啉衍生物,并基于对45种取代的喹啉衍生物作为hDHODH抑制剂的3D QSAR研究,预测了它们的hDHODH抑制活性,并预测了毒性。将设计的化合物对接至hDHODH的结合位点。选择显示出良好的预测活性,无毒性和良好的对接分数的设计化合物进行合成,并在酶抑制试验中体外筛选作为hDHODH抑制剂,在MTT试验中作为癌细胞系(HT-29和MDA)的抗癌药-MB-231)。